Breast Cancer
Showing NaN - NaN of 158
Breast Cancer, Insomnia, Weight Gain Trial in Washington, Baltimore, Lutherville (Cognitive-Behavioral Therapy for Insomnia
Not yet recruiting
- Breast Cancer
- +2 more
- Cognitive-Behavioral Therapy for Insomnia (CBT-I)
- Sleep Education Control (EDU)
-
Washington, District of Columbia
- +3 more
Mar 21, 2023
Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Breast Carcinoma Trial in Washington, Baltimore, Hackensack
Active, not recruiting
- Breast Cancer
- +2 more
-
Washington, District of Columbia
- +4 more
Jan 31, 2023
Breast Cancer Trial in United States (HKI-272, Surgical Resection, Capecitabine)
Active, not recruiting
- Breast Cancer
- HKI-272
- +3 more
-
San Francisco, California
- +17 more
Jan 30, 2023
Breast Cancer Trial in United States (Positron emission tomography (PET), Trastuzumab, Pertuzumab)
Active, not recruiting
- Breast Cancer
- Positron emission tomography (PET)
- +2 more
-
Birmingham, Alabama
- +9 more
Jan 20, 2023
Breast Cancer Trial in Washington, Baltimore (Outcomes4Me, Semi-structured interview)
Recruiting
- Breast Cancer
- Outcomes4Me
- Semi-structured interview
-
Washington, District of Columbia
- +1 more
Jan 13, 2023
Cancer in Patients on Dapagliflozin and Other Antidiabetic
Recruiting
- Breast Cancer
- Bladder Cancer
-
Wilmington, Delaware
- +3 more
Jan 13, 2023
Breast Cancer, Triple Negative Breast Cancer Trial in United States (Capecitabine, Talazoparib, Atezolizumab)
Recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Capecitabine
- +4 more
-
Washington, District of Columbia
- +5 more
Jan 12, 2023
Breast Cancer Trial in Worldwide (trastuzumab, trastuzumab emtansine)
Active, not recruiting
- Breast Cancer
- trastuzumab
- trastuzumab emtansine
-
Anchorage, Alaska
- +275 more
Dec 13, 2022
Breast Cancer Trial in Worldwide (Olaparib, Placebo)
Breast Cancer Trial in United States (Photon, Proton)
Recruiting
- Breast Cancer
- Photon
- Proton
-
Birmingham, Alabama
- +40 more
Nov 18, 2022
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
Breast Cancer Trial in Worldwide (exemestane, tamoxifen, triptorelin)
TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)
Active, not recruiting
- TNBC - Triple-Negative Breast Cancer
- Breast Cancer
- Trilaciclib
- +3 more
-
Birmingham, Alabama
- +111 more
Oct 25, 2022
Breast Cancer Trial in Washington, Charlotte, Salt Lake City (Talazoparib, Avelumab)
Active, not recruiting
- Breast Cancer
-
Washington, District of Columbia
- +1 more
Oct 10, 2022
Breast Cancer, Colorectal Cancer, Ovarian Cancer Trial in United States (ATRC-101, Pembrolizumab, Pegylated liposomal
Recruiting
- Breast Cancer
- +15 more
- ATRC-101
- +2 more
-
Phoenix, Arizona
- +10 more
Sep 28, 2022
Breast Cancer Trial in United States (NeuVax vaccine, Trastuzumab, GM-CSF)
Completed
- Breast Cancer
- NeuVax vaccine
- +2 more
-
Santa Monica, California
- +23 more
Sep 15, 2022
Biomarkers in Subjects With Untreated Solid Tumors
Completed
- Breast Cancer
- +12 more
- Blood Sample Collection
-
Phoenix, Arizona
- +118 more
Aug 31, 2022
Malignant Tumor of Breast, Breast Cancer Trial in United States (Genomically Directed Monotherapy, Observation/Standard Therapy)
Active, not recruiting
- Malignant Neoplasm of Breast
- Breast Cancer
- Genomically Directed Monotherapy
- Observation/Standard Therapy
-
Birmingham, Alabama
- +28 more
Aug 30, 2022
Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus
Recruiting
- Mesothelioma
- +14 more
- NGM707
- NGM707 plus pembrolizumab
-
Los Angeles, California
- +13 more
Aug 16, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan
- +3 more
-
Chandler, Arizona
- +226 more
Aug 11, 2022
Breast Cancer Trial in United States (bicalutamide, diagnostic laboratory biomarker analysis, immunohistochemistry staining
Breast Cancer Trial in Worldwide (Elacestrant, Standard of Care)
Active, not recruiting
- Breast Cancer
- Elacestrant
- Standard of Care
-
Tucson, Arizona
- +167 more
Jul 19, 2022
Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer Trial in Washington, Baltimore (Simvastatin,
Active, not recruiting
- Breast Cancer
- +3 more
-
Washington, District of Columbia
- +1 more
May 19, 2022